Clovis Oncology Inc (NASDAQ:CLVS)

50.17
Delayed Data
As of Apr 20
 -1.15 / -2.24%
Today’s Change
45.42
Today|||52-Week Range
99.45
-26.22%
Year-to-Date
Clovis' (CLVS) Rubraca Gets FDA Nod as Maintainence Therapy
Apr 09 / Zacks.com - Paid Partner Content
Clovis Oncology (CLVS) Surges: Stock Moves 5.9% Higher
Apr 09 / Zacks.com - Paid Partner Content